A potent targeted cancer nanotherapeutic
Sign Up to like & getrecommendations! Published in 2019 at "Nature Biomedical Engineering"
DOI: 10.1038/s41551-019-0390-7
Abstract: An antibody-modified nanoparticle encapsulating a pH-sensitive taxane prodrug, and targeting an overexpressed receptor in tumours, improves the tolerability and anticancer efficacy of the active drug in multiple animal models. read more here.
Keywords: potent targeted; cancer nanotherapeutic; targeted cancer;